The med-tech giant’s shares tick upward as defibrillator market stabilizes.
|
Boston Scientific shares dip 7 percent after warnings some devices could cause problems.
|
Firm stirs up the market with a test that could break the hearts of device makers.
|
An independent panel suggests how the troubled heart device maker can better its patient safety communication skills.
|
BSX 4Q sales slip; Boston Scientific quarterly sales fall; St. Jude pacemakers approved
|
Boston Scientific and Guidant left Johnson & Johnson all alone by the telephone. So just who will J&J call?
|
Mini parachutes for flu meds; firms launch counterfeit drug war; St. Jude gets OK on ANS; Ortho Evra warning; Pharmaxis Raises $63M; Align suit advances.
|
Heart device manufacturer acquires Advanced Neuromodulation Systems and reports earnings rose 29 percent.
|
Class-action lawsuit dropped against GeoPharma; Inovio receives patent; St. Jude’s heart lead in Japan.
|